Status:
UNKNOWN
May the Risk of PHLF be Predicted With Preoperative Liver Gadoxetate MRI
Lead Sponsor:
University Hospital, Linkoeping
Conditions:
MRI
Liver Resection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Post hepatectomy liver failure (PHLF) is one of the most severe complications after liver re-section. Preoperative evaluation of liver function is complicated and imprecise. The volume and function ne...
Detailed Description
Post hepatectomy liver failure (PHLF) is one of the most severe complications after liver re-section. Preoperative evaluation of liver function is complicated and imprecise. The volume and function ne...
Eligibility Criteria
Inclusion
- Patients who have had a Primovist MRI within 8 weeks before hemihepatectomy or extended hemi-hepatectomy +/- bile duct anastomosis independent of diagnosis.
- Patients with cirrhosis who have had a Primovist MRI within 8 weeks before resection of more than one liver segment
- Patients who had liver volume augmentation with a pre-operative Primovist MRI less than 2 weeks before resection
- Patients who have had a Primovist MRI within 6 weeks be-fore any liver resection where PHLF or death within 90 days occurred.
- \-
Exclusion
- \<18 years of age
- Resection was not performed -
Key Trial Info
Start Date :
December 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04692259
Start Date
December 29 2020
End Date
June 30 2024
Last Update
November 29 2023
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Rikshospitalet
Copenhagen, Denmark
2
Helsingfors Universitetssjukhus
Helsinki, Finland
3
Rikshospitalet
Oslo, Norway
4
Karolinska Universitetssjukhuset Huddinge
Stockholm, Södermanland County, Sweden